Predictors of early death risk among untransplanted patients with combined immunodeficiencies affecting cellular and humoral immunity: A multicenter report.
Waleed Al HerzAli H ZiyabMehdi AdeliTariq Al FarsiSuleiman Al-HammadiAmna Ali Al KuwaitiMaryam Al-NesfNashat Al SukaitiSalem Al-TamemiHiba ShendiPublished in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2022)
Combined immunodeficiencies patients with a history of Candida infections, sepsis, hepatomegaly, or severe T-lymphopenia should be given priority for HSCT to avoid early death.